ArticleJournal of market access & health policy2014

Economic impact of new active substance status on EU payers' budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosis.

Mondher Toumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.